SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-280679
Filing Date
2023-11-20
Accepted
2023-11-20 16:26:02
Documents
14
Period of Report
2023-11-17
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d608859d8k.htm   iXBRL 8-K 36919
2 EX-3.1 d608859dex31.htm EX-3.1 8048
3 EX-3.2 d608859dex32.htm EX-3.2 81593
  Complete submission text file 0001193125-23-280679.txt   279177

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acer-20231117.xsd EX-101.SCH 2506
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20231117_lab.xml EX-101.LAB 19455
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20231117_pre.xml EX-101.PRE 12130
8 EXTRACTED XBRL INSTANCE DOCUMENT d608859d8k_htm.xml XML 3492
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 231423108
SIC: 2834 Pharmaceutical Preparations